NAD+
$Endogenous coenzyme; Not a peptide
NAD+ is a coenzyme involved in energy metabolism, sirtuin activity, DNA repair, and cellular stress responses. It appears in peptide-clinic settings because it is often injected or infused, not because it is chemically a peptide.
NAD biology is real, but blood infusion effects do not map neatly to intracellular NAD pools in every tissue. Symptoms during infusion, changes in fatigue, and biomarker shifts should not be overinterpreted as global cellular rejuvenation. Distinguish NAD+ itself from precursors such as NR, NMN, niacin, and tryptophan-pathway support.
Think about rate of infusion, methylation demand, liver metabolism, and objective outcomes rather than “felt energy” alone.
Classification details
- NAD+ is a central redox coenzyme involved in energy metabolism, sirtuin biology, DNA-repair signaling, and cellular stress response.
- NAD+ is a coenzyme rather than a peptide, but it belongs in the guide because it is often used in the same clinics and stacks. NAD+ itself is distinct from precursors like NR, NMN, niacin, and tryptophan-pathway strategies.
- NAD+ participates in oxidation-reduction reactions and serves as substrate for enzymes such as sirtuins and PARPs.
- NAD biology supports redox reactions, sirtuins, PARPs, CD38-related consumption, and mitochondrial metabolism. Raising NAD markers does not automatically mean improved clinical outcomes.